[ET Net News Agency, 21 July 2021] LifeTech Scientific Corporation (01302) said for the
six months ended 30 June 2021, the group is expected to record no less than RMB200 million
in profit attributable to owners of the company, representing an increase ranging from
100% to 110% as compared to the corresponding period in 2020.
Such significant increase was primarily attributable to (i) an increase in the sales
revenue and gross profit from each business segment of the group, its overall gross profit
recorded an increase ranging from 70% to 75% as compared to the corresponding period in
2020; and (ii) the investment income generated from Ally Bridge Group Innovation Capital
Partners III, L.P. was approximately RMB27.7 million for the six months ended 30 June
2021, representing an increase of approximately RMB17.7 million as compared to the
corresponding period in 2020. (RC)